Your browser doesn't support javascript.
loading
The efficacy and safety of ezetimibe for treatment of dyslipidemia after heart transplantation.
Crespo-Leiro, M G; Paniagua, M J; Marzoa, R; Grille, Z; Naya, C; Flores, X; Rodriguez, J A; Mosquera, V; Franco, R; Castro-Beiras, A.
Affiliation
  • Crespo-Leiro MG; Heart Transplant Unit, Cardiology Service, Complejo Hospitalario Universitario Juan Canalejo, La Coruña, Spain. Marisa_Crespo@canalejo.org
Transplant Proc ; 40(9): 3060-2, 2008 Nov.
Article in En | MEDLINE | ID: mdl-19010194
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Postoperative Complications / Azetidines / Heart Transplantation / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Dyslipidemias / Anticholesteremic Agents Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Transplant Proc Year: 2008 Document type: Article Affiliation country: España Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Postoperative Complications / Azetidines / Heart Transplantation / Hydroxymethylglutaryl-CoA Reductase Inhibitors / Dyslipidemias / Anticholesteremic Agents Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Transplant Proc Year: 2008 Document type: Article Affiliation country: España Country of publication: Estados Unidos